These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12673480)

  • 1. Persistent ascites after ovarian hyperstimulation syndrome and administration of mifepristone (RU 486) for the termination of pregnancy.
    Gnoth C; Halbe E; Freundl G
    Arch Gynecol Obstet; 2003 Apr; 268(1):65-8. PubMed ID: 12673480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous ovarian hyperstimulation syndrome (OHSS): a rare but important differential diagnosis for abdominal distension in early pregnancy.
    Irvine LM
    J Obstet Gynaecol; 2011 May; 31(4):338-9. PubMed ID: 21534759
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical abortion.
    Bardin CW; Robbins A; O'Connor BM; Spitz I
    Curr Ther Endocrinol Metab; 1997; 6():305-11. PubMed ID: 9174759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks.
    Salomon LJ; Rozenberg P; Szekeres-Bartho J; Malagrida L; Giudicelli Y; Ville Y
    J Matern Fetal Neonatal Med; 2005 May; 17(5):353-6. PubMed ID: 16147850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone in abortion care.
    Schreiber C; Creinin M
    Semin Reprod Med; 2005 Feb; 23(1):82-91. PubMed ID: 15714392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: a most peculiar family with spontaneous, recurrent ovarian hyperstimulation syndrome.
    Di Carlo C; Savoia F; Ferrara C; Tommaselli GA; Bifulco G; Nappi C
    Gynecol Endocrinol; 2012 Aug; 28(8):649-51. PubMed ID: 22313155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone (RU486) and voluntary termination of pregnancy: enigmatic variations or anecdotal religion-based attitudes?
    Baulieu EE; Seidman DS; Hajri S
    Hum Reprod; 2001 Oct; 16(10):2243-4. PubMed ID: 11574524
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergency ultrasound diagnosis of ovarian hyperstimulation syndrome: case report.
    Frasure SE; Rempell JS; Noble VE; Liteplo AS
    J Emerg Med; 2012 Aug; 43(2):e129-32. PubMed ID: 22525699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute ascites and abdominal pain from ovarian hyperstimulation syndrome (OHSS).
    Kiel J
    Am J Emerg Med; 2019 Apr; 37(4):794.e5-794.e6. PubMed ID: 30598375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antifertility effects of mifepristone and epostane alone and in combination in rats].
    Liu CG; Lin ZM; Li WK; Wu XY; Wang ZX; Xue T; Xu RY
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):437-40. PubMed ID: 8010036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mifepristone: current knowledge and emerging prospects.
    Kakade AS; Kulkarni YS
    J Indian Med Assoc; 2014 Jan; 112(1):36-40. PubMed ID: 25935948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abscess formation in ovarian endometriomas after failure of mifepristone-induced abortion.
    Chao AS; Chang SD; Wang CJ; Chao A; Wang TH
    Clin Exp Obstet Gynecol; 2016; 43(5):766-768. PubMed ID: 30074336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unilateral pleural effusion in ovarian hyperstimulation syndrome].
    Barile D; Bataille Y; Duysinx BC; Lambermont B; Louis R
    Rev Med Liege; 2008; 63(7-8):474-9. PubMed ID: 18771225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound evaluation of the endometrium after medical termination of pregnancy.
    Cowett AA; Cohen LS; Lichtenberg ES; Stika CS
    Obstet Gynecol; 2004 May; 103(5 Pt 1):871-5. PubMed ID: 15121559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin.
    Chou SY; Chen CY; Chiang HK; Chow PK; Wang CC; Hsu CS
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):48-52. PubMed ID: 17272208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome.
    Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y
    Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventriculoperitoneal shunt failure as a secondary complication of ovarian hyperstimulation syndrome. Case report.
    Lee GY; Daniel RT; Jones NR
    J Neurosurg; 2002 Oct; 97(4):992-4. PubMed ID: 12405393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of mifepristone.
    Tang OS; Ho PC
    Gynecol Endocrinol; 2006 Dec; 22(12):655-9. PubMed ID: 17162706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.